Intracellular chromium reduction

Biochim Biophys Acta. 1987 Oct 22;931(1):10-5. doi: 10.1016/0167-4889(87)90044-9.

Abstract

Two steps are involved in the uptake of Cr(VI): (1) the diffusion of the anion CrO4(2-) through a facilitated transport system, presumably the non-specific anion carrier and (2) the intracellular reduction of Cr(VI) to Cr(III). The intracellular reduction of Cr(VI), keeping the cytoplasmic concentration of Cr(VI) low, facilitates accumulation of chromate from extracellular medium into the cell. In the present paper, a direct demonstration of intracellular chromium reduction is provided by means of electron paramagnetic (spin) resonance (EPR) spectroscopy. Incubation of metabolically active rat thymocytes with chromate originates a signal which can be attributed to a paramagnetic species of chromium, Cr(V) or Cr(III). The EPR signal is originated by intracellular reduction of chromium since: (1) it is observed only when cells are incubated with chromate, (2) it is present even after extensive washings of the cells in a chromium-free medium; (3) it is abolished when cells are incubated with drugs able to reduce the glutathione pool, i.e., diethylmaleate or phorone; and (4) it is abolished when cells are incubated in the presence of a specific inhibitor of the anion carrier, 4-acetamido-4'-isothiocyanatostilbene-2-2'-disulfonic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Membrane / metabolism
  • Chromates / metabolism
  • Chromium / metabolism*
  • Electron Spin Resonance Spectroscopy
  • Intracellular Fluid / metabolism
  • Ketones / pharmacology
  • Maleates / pharmacology
  • Oxidation-Reduction
  • Rats
  • Rats, Inbred Strains
  • Thymus Gland / drug effects
  • Thymus Gland / metabolism*

Substances

  • Chromates
  • Ketones
  • Maleates
  • Chromium
  • phorone
  • diethyl maleate
  • chromic acid